Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gravitas Kannavis is a hemp-processing business operating as a division/brand of Gravitas Infinitum, a health and wellness holding company founded in 2018. The business appears focused on industrial-scale whole-plant hemp biomass processing, using proprietary processing equipment and associated software/business services rather than developing conventional therapeutics. Public materials describe its Ultra Series processors as capable of extracting hemp oils and other high-value molecules and separating fiber for plastics, with a broader strategy to build biomass processing hubs and mobile processing capabilities. Gravitas Kannavis also references farmer/grower and nutraceutical programs under the broader Gravitas platform. Based on available evidence, it is best characterized as a commercial hemp-processing technology and services operation adjacent to health/wellness rather than a biotech or pharma drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gravitas Kannavis.